RemediumOne was involved in one Ophthalmology clinical trial. 80+ participants were enrolled to this study in 6 centers spread across the country.
January 15, 2020
Sri Lanka participated in this global multi-country multi-center project. The study design was randomized (1:1) double‐masked, vehicle‐controlled, multi‐center, parallel group study with two **** treatment arms: ****** Ophthalmic Solution 0 (“******”) and ***** Vehicle (“Vehicle”). […]READ MORE